X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417 | +145.3% | 382,134 | +334.8% | 0.00% | – |
| Q2 2023 | $170 | – | 87,879 | +87779.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -98.7% | 0.00% | – |
| Q1 2022 | $14,000 | -61.1% | 7,804 | -50.0% | 0.00% | – |
| Q4 2021 | $36,000 | -30.8% | 15,608 | +57.7% | 0.00% | – |
| Q3 2021 | $52,000 | -51.4% | 9,899 | -39.7% | 0.00% | – |
| Q2 2021 | $107,000 | -41.5% | 16,410 | -22.8% | 0.00% | – |
| Q1 2021 | $183,000 | +120.5% | 21,245 | +63.5% | 0.00% | – |
| Q4 2020 | $83,000 | +8200.0% | 12,993 | +9180.7% | 0.00% | – |
| Q2 2020 | $1,000 | -99.5% | 140 | -99.2% | 0.00% | – |
| Q4 2019 | $188,000 | +154.1% | 17,563 | +200.1% | 0.00% | – |
| Q3 2019 | $74,000 | +1750.0% | 5,852 | +2288.6% | 0.00% | – |
| Q1 2019 | $4,000 | – | 245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,109,000 | 3.48% |
| SV Health Investors, LLC | 311,490 | $2,109,000 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,648,485 | $11,160,000 | 1.04% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,268,000 | 0.91% |
| Ikarian Capital, LLC | 724,680 | $4,907,000 | 0.36% |
| BVF INC/IL | 792,892 | $5,368,000 | 0.29% |
| Opaleye Management Inc. | 75,000 | $508,000 | 0.10% |
| Orbimed Advisors | 1,086,493 | $7,356,000 | 0.09% |
| RA Capital Management | 559,494 | $3,788,000 | 0.07% |
| Bleichroeder LP | 35,730 | $242,000 | 0.04% |